Daniel Heintel

1.5k total citations
30 papers, 846 citations indexed

About

Daniel Heintel is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel Heintel has authored 30 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 14 papers in Molecular Biology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel Heintel's work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Multiple Myeloma Research and Treatments (10 papers). Daniel Heintel is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Multiple Myeloma Research and Treatments (10 papers). Daniel Heintel collaborates with scholars based in Austria, Germany and Czechia. Daniel Heintel's co-authors include Alexander Gaiger, Ilse Schwarzinger, Ulrich Jäger, Heinz Ludwig, Ulrich Jäger, Niklas Zojer, Arnold Bolomsky, Trang Le, Martin Schreder and Christine Mannhalter and has published in prestigious journals such as Blood, International Journal of Cancer and British Journal of Haematology.

In The Last Decade

Daniel Heintel

27 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Heintel Austria 13 442 346 322 289 205 30 846
Alicja Gruszka Italy 20 395 0.9× 378 1.1× 274 0.9× 380 1.3× 259 1.3× 36 945
Rocí­o Benito Spain 17 295 0.7× 289 0.8× 260 0.8× 134 0.5× 128 0.6× 59 745
Shuhua Yi China 15 310 0.7× 238 0.7× 229 0.7× 315 1.1× 280 1.4× 119 802
Domenico Levato Italy 20 309 0.7× 674 1.9× 205 0.6× 461 1.6× 168 0.8× 29 974
Marek Hus Poland 17 366 0.8× 239 0.7× 461 1.4× 87 0.3× 319 1.6× 110 869
Takashi Akasaka Japan 15 222 0.5× 229 0.7× 92 0.3× 323 1.1× 194 0.9× 45 660
Nadine Juge‐Morineau France 12 162 0.4× 149 0.4× 227 0.7× 250 0.9× 266 1.3× 18 553
L Mangoni Italy 18 231 0.5× 242 0.7× 504 1.6× 161 0.6× 220 1.1× 53 886
Larry Mansouri Sweden 19 394 0.9× 591 1.7× 79 0.2× 397 1.4× 170 0.8× 37 944
Cristi Gidel United States 7 681 1.5× 360 1.0× 620 1.9× 102 0.4× 264 1.3× 7 1.0k

Countries citing papers authored by Daniel Heintel

Since Specialization
Citations

This map shows the geographic impact of Daniel Heintel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Heintel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Heintel more than expected).

Fields of papers citing papers by Daniel Heintel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Heintel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Heintel. The network helps show where Daniel Heintel may publish in the future.

Co-authorship network of co-authors of Daniel Heintel

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Heintel. A scholar is included among the top collaborators of Daniel Heintel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Heintel. Daniel Heintel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stühlinger, Markus, Ansgar Weltermann, Philipp B. Staber, et al.. (2019). Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk. Wiener klinische Wochenschrift. 132(3-4). 97–109. 8 indexed citations
2.
Bolomsky, Arnold, Wolfgang Hübl, Stefano Spada, et al.. (2017). IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide‐dexamethasone therapy in multiple myeloma. American Journal of Hematology. 92(3). 269–278. 11 indexed citations
3.
Bolomsky, Arnold, Dirk Hose, Martin Schreder, et al.. (2015). Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma. Journal of Hematology & Oncology. 8(1). 10–10. 25 indexed citations
4.
Ludwig, Heinz, Elisabeth Rauch, Zdeněk Adam, et al.. (2014). Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study. Haematologica. 100(3). 385–391. 19 indexed citations
5.
Ludwig, Heinz, Elisabeth Rauch, Zdeněk Adam, et al.. (2014). Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study. Blood. 124(21). 3484–3484. 1 indexed citations
6.
Porpaczy, Edit, Stefanie Tauber, Martin Bilban, et al.. (2013). Lipoprotein lipase in chronic lymphocytic leukaemia – Strong biomarker with lack of functional significance. Leukemia Research. 37(6). 631–636. 16 indexed citations
7.
Bolomsky, Arnold, Dirk Hose, Martin Schreder, et al.. (2012). Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Is Downregulated in Multiple Myeloma with Consequneces for Myeloma Cell Growth and Bone Disease. Blood. 120(21). 3947–3947. 2 indexed citations
8.
Jäger, Ulrich, Michael Fridrik, Markus Zeitlinger, et al.. (2012). Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. Haematologica. 97(9). 1431–1438. 80 indexed citations
9.
10.
Lopez‐Girona, Antonia, Daniel Heintel, Derek Mendy, et al.. (2011). Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response. British Journal of Haematology. 154(3). 325–336. 137 indexed citations
11.
Gruber, Michaela, Edit Porpaczy, Cathrin Skrabs, et al.. (2011). Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab. Annals of Hematology. 90(10). 1131–1136. 10 indexed citations
12.
Heintel, Daniel, Cathrin Skrabs, Alexander W. Hauswirth, et al.. (2009). Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age. Annals of Hematology. 89(2). 163–169. 12 indexed citations
13.
Kainz, Birgit, Medhat Shehata, Martin Bilban, et al.. (2007). Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high‐risk B‐cell chronic lymphocytic leukemia. International Journal of Cancer. 121(9). 1984–1993. 55 indexed citations
14.
Bilban, Martin, Daniel Heintel, Theresa Scharl, et al.. (2006). Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia. 20(6). 1080–1088. 56 indexed citations
15.
Heintel, Daniel, Dirk Kienle, Medhat Shehata, et al.. (2005). High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia. 19(7). 1216–1223. 116 indexed citations
16.
17.
Gaiger, Alexander, Daniel Heintel, & Ulrich Jäger. (2004). Novel molecular diagnostic and therapeutic targets in chronic lymphocytic leukaemia. European Journal of Clinical Investigation. 34(s2). 25–30. 9 indexed citations
18.
Heintel, Daniel, Berthold Streubel, Trang Le, et al.. (2003). Burkitt lymphoma following splenic marginal zone lymphoma. Cancer Genetics and Cytogenetics. 141(1). 86–88. 9 indexed citations
19.
Kainz, Birgit, Daniel Heintel, Rodrig Marculescu, et al.. (2002). Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16). The Hematology Journal. 3(6). 283–289. 61 indexed citations
20.
Heintel, Daniel, Ilse Schwarzinger, Renate Thalhammer, et al.. (2001). Association of CD38 Antigen Expression with Other Prognostic Parameters in Early Stages of Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 42(6). 1315–1321. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicja Gruszka Breakdown of academic impact, for papers by Rocí­o Benito Breakdown of academic impact, for papers by Shuhua Yi Breakdown of academic impact, for papers by Domenico Levato Breakdown of academic impact, for papers by Marek Hus Breakdown of academic impact, for papers by Takashi Akasaka Breakdown of academic impact, for papers by Nadine Juge‐Morineau Breakdown of academic impact, for papers by L Mangoni Breakdown of academic impact, for papers by Larry Mansouri Breakdown of academic impact, for papers by Cristi Gidel
Rankless by CCL
2026